Additional information
| Use in sports | Not typically used in sports |
|---|---|
| Formula | C16H14F3N3O2S |
| Side effects | Headache, diarrhea, abdominal pain, nausea, dizziness |
| Effects | Decreases gastric acid secretion |
| Dosage (sports) | Not applicable |
| Dosage (medical) | 15 mg to 30 mg daily |
| Half-life | 1 to 1.5 hours |
| Main action | Reduces stomach acid production |
| Substance class | Proton pump inhibitor |
| Chemical name | 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole |
| Water Retention | No significant effect |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Prevacid |
| Blood pressure | Generally has no effect on blood pressure |
| Also known as | Lansox, Takepron, Agopton |
| Strength | 30 mg |
| Lab Test | Not regularly required in treatment monitoring |
| Hepatotoxicity | Rare, but some cases have been reported |
| Manufacturer | Cipla |
Reviews
There are no reviews yet.